Ms Sophie Elizabeth Leeds, | |
401 Castle Creek Rd, Aspen, CO 81611-1159 | |
(970) 544-1347 | |
(970) 544-1544 |
Full Name | Ms Sophie Elizabeth Leeds |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 401 Castle Creek Rd, Aspen, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831898642 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0007818 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Sophie Elizabeth Leeds, 2909 N 118th St Ste 200, Omaha, NE 68164-3643 Ph: (201) 638-9924 | Ms Sophie Elizabeth Leeds, 401 Castle Creek Rd, Aspen, CO 81611-1159 Ph: (970) 544-1347 |
News Archive
Medicare fraud charges have been filed against six individuals in the continuing operation of the Medicare Fraud Strike Force in Houston, Assistant Attorney General Lanny A. Breuer of the Criminal Division, U.S. Attorney for the Southern District of Texas Tim Johnson and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS), announced today.
Although it is inexpensive, easy to obtain and poses little health risk, women undergoing in vitro fertilization (IVF) cannot rely upon aspirin to help them become pregnant, according to a systematic review of nine studies.
Researchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer. By engineering a streptococcal bacterial toxin to attach itself to tumour cells, they are forcing the immune system to recognize and attack the cancer.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.
› Verified 3 days ago